Status:
RECRUITING
Developing Breast (Cancer) Organoids
Lead Sponsor:
Maastricht Radiation Oncology
Collaborating Sponsors:
Maastricht University Medical Center
Maastricht University
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Currently, only a few validated biomarkers and models exist guiding or predicting treatment response for specific patient groups. Therefore, a patient-tailored clinical model needs to be developed to ...
Detailed Description
The investigators will select patients with a diagnosis of breast cancer who undergo breast surgery. Patients will be asked informed consent for the use of a small (0,2-1 cm3) sample of the excised br...
Eligibility Criteria
Inclusion
- Female,
- \>18 years,
- Family Anamneses
- Breast cancer (proven by histopathology), Included subtypes; (ER-,PR- HER2-); (ER+, PR+, HER2-); (ER+, PR+ HER2+).
- Primary surgery (lumpectomy or mastectomy)
Exclusion
- \- Physically or mentally incapable or incompetent to sign informed consent
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2028
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05317221
Start Date
September 1 2022
End Date
May 1 2028
Last Update
May 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Center
Maastricht, Netherlands, 6202 AZ